Sequenom Settles on HiSeq for Trisomy 21 Test; Completes Technical Study | GenomeWeb

By Julia Karow

Sequenom has selected the Illumina HiSeq 2000 platform to run its commercial non-invasive trisomy 21 screening test at launch, currently planned for the fourth quarter of 2011, according to a company official.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.